{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:42:28Z","timestamp":1790523748517,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:00:00Z","timestamp":1448582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:00:00Z","timestamp":1448582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endothelial progenitor cells (EPC) are able to migrate to tumor vasculature. These cells, if genetically modified, can be used as vehicles to deliver toxic material to, or express anticancer proteins in tumor. To test this hypothesis, we developed several single, endothelial-specific and doxycycline-inducible self-inactivating (SIN) lentiviral vectors. Two distinct expression cassettes were inserted into a SIN-vector: one controlled by an endothelial lineage-specific, murine vascular endothelial cadherin (mVEcad) promoter for the expression of a transactivator, rtTA2S-M2; and the other driven by an inducible promoter, TREalb, for a firefly luciferase reporter gene. We compared the expression levels of luciferase in different vector constructs, containing either the same or opposite orientation with respect to the vector sequence. The results showed that the vector with these two expression cassettes placed in opposite directions was optimal, characterized by a robust induction of the transgene expression (17.7- to 73-fold) in the presence of doxycycline in several endothelial cell lines, but without leakiness when uninduced. In conclusion, an endothelial lineage-specific single inducible SIN lentiviral vector has been developed. Such a lentiviral vector can be used to endow endothelial progenitor cells with anti-tumor properties.<\/jats:p>","DOI":"10.1038\/srep17166","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T10:57:39Z","timestamp":1448621859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells"],"prefix":"10.1038","volume":"5","author":[{"given":"Guanghua","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gabriela","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Fernandez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milosz P.","family":"Kawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,27]]},"reference":[{"key":"BFsrep17166_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/cancers5030815","volume":"5","author":"T Liechtenstein","year":"2013","unstructured":"Liechtenstein, T., Perez-Janices, N. & Escors, D. Lentiviral vectors for cancer immunotherapy and clinical applications. Cancers 5, 815 (2013).","journal-title":"Cancers"},{"key":"BFsrep17166_CR2","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1093\/ejcts\/ezt382","volume":"44","author":"M Pirro","year":"2013","unstructured":"Pirro, M. et al. Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival. Eur. J. Cardiothorac. Surg. 44, e245\u2013e252 (2013).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"BFsrep17166_CR3","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1158\/1078-0432.CCR-13-0462","volume":"19","author":"P De la Puente","year":"2013","unstructured":"De la Puente, P., Muz, B., Azab, F. & Azab, A. K. Cell trafficking of endothelial progenitor cells in tumor progression. Clin. Cancer Res. 19, 3360\u20133368 (2013).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep17166_CR4","first-page":"141","volume":"101","author":"CG Rodrigues","year":"2013","unstructured":"Rodrigues, C. G. et al. VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells. Arq. Bras. Cardiol. 101, 141\u2013148 (2013).","journal-title":"Arq. Bras. Cardiol."},{"key":"BFsrep17166_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/1354750X.2013.810666","volume":"18","author":"X Ha","year":"2013","unstructured":"Ha, X. et al. Identification and clinical significance of circulating endothelial progenitor cells in gastric cancer. Biomarkers 18, 487\u2013492 (2013).","journal-title":"Biomarkers"},{"key":"BFsrep17166_CR6","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1073\/pnas.96.6.2988","volume":"96","author":"SS Case","year":"1999","unstructured":"Case, S. S. et al. Stable transduction of quiescent CD34\u2009+\u2009CD38\u2212 human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl Acad. Sci. USA 96, 2988\u20132993 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFsrep17166_CR7","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1182\/blood.V100.13.4391","volume":"100","author":"W Piacibello","year":"2002","unstructured":"Piacibello, W. et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary and tertiary multilineage repopulation in NOD\/SCID mice. Blood 100, 4391\u20134400 (2002).","journal-title":"Blood"},{"key":"BFsrep17166_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/ars.2012.4800","volume":"19","author":"S Vidoni","year":"2013","unstructured":"Vidoni, S., Zanna, C., Rugolo, M., Sarzi, E. & Lenaers, G. Why mitochondria must fuse to maintain their genome integrity. Antioxid. Redox Signaling 19, 379\u2013388 (2013).","journal-title":"Antioxid. Redox Signaling"},{"key":"BFsrep17166_CR9","doi-asserted-by":"publisher","first-page":"6750","DOI":"10.1074\/jbc.273.12.6750","volume":"273","author":"S Gory","year":"1998","unstructured":"Gory, S. et al. Requirement of a GT Box (Sp1 Site) and two ets binding sites for vascular endothelial cadherin gene transcription. J. Biol. Chem. 273, 6750\u20136755 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFsrep17166_CR10","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1158\/0008-5472.CAN-03-3061","volume":"64","author":"M Zabala","year":"2004","unstructured":"Zabala, M. et al. Optimization of the tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res. 64, 2799\u20132804 (2004).","journal-title":"Cancer Res."},{"key":"BFsrep17166_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1089\/10430340252769734","volume":"13","author":"S Lamartina","year":"2002","unstructured":"Lamartina, S. et al. Stringent Control of Gene Expression In Vivo by Using Novel Doxycycline-Dependent Trans-Activators. Hum. Gene Ther. 13, 199\u2013210 (2002).","journal-title":"Hum. Gene Ther."},{"key":"BFsrep17166_CR12","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1073\/pnas.130192197","volume":"97","author":"S Urlinger","year":"2000","unstructured":"Urlinger, S. et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl Acad. Sci. USA 97, 7963\u20137968 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFsrep17166_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1525-0016(02)00060-6","volume":"7","author":"MG Kramer","year":"2003","unstructured":"Kramer, M. G. et al. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol. Ther. 7, 375\u2013385 (2003).","journal-title":"Mol. Ther."},{"key":"BFsrep17166_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymthe.2005.09.012","volume":"13","author":"I Barde","year":"2006","unstructured":"Barde, I. et al. Efficient control of gene expression in the hematopoietic system using a single tet-on inducible lentiviral vector. Mol. Ther. 13, 382\u2013390 (2006).","journal-title":"Mol. Ther."},{"key":"BFsrep17166_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00296-011-2002-z","volume":"34","author":"Q Shi","year":"2014","unstructured":"Shi, Q. et al. Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system. Rheumatol. Int. 34, 51\u201357 (2014).","journal-title":"Rheumatol. Int."},{"key":"BFsrep17166_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJM200301163480314","volume":"348","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina, S. et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255\u2013256 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep17166_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/mthe.2002.0542","volume":"5","author":"E Vigna","year":"2002","unstructured":"Vigna, E. et al. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 5, 252\u2013261 (2002).","journal-title":"Mol. Ther."},{"key":"BFsrep17166_CR18","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","volume":"72","author":"H Miyoshi","year":"1998","unstructured":"Miyoshi, H., Bl\u00f6mer, U., Takahashi, M., Gage, F. H. & Verma, I. M. Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150\u20138157 (1998).","journal-title":"J. Virol."},{"key":"BFsrep17166_CR19","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463\u20138471 (1998).","journal-title":"J. Virol."},{"key":"BFsrep17166_CR20","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1093\/nar\/gni062","volume":"33","author":"D Markusic","year":"2005","unstructured":"Markusic, D., Oude-Elferink, R., Das, A. T., Berkhout, B. & Seppen, J. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res. 33, e63, 10.1093\/nar\/gni062 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep17166_CR21","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1073\/pnas.96.6.2615","volume":"96","author":"A Recchia","year":"1999","unstructured":"Recchia, A. et al. Site-specific integration mediated by a hybrid adenovirus\/adeno-associated virus vector. Proc. Natl Acad. Sci. USA 96, 2615\u20132620 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFsrep17166_CR22","doi-asserted-by":"publisher","first-page":"e61412","DOI":"10.1371\/journal.pone.0061412","volume":"8","author":"J Bai","year":"2013","unstructured":"Bai, J., Li, J. & Mao, Q. Construction of a single lentiviral vector containing tetracycline-inducible Alb-uPA for transduction of uPA expression in murine hepatocytes. PLoS ONE 8, e61412, 10.1371\/journal.pone.0061412 (2013).","journal-title":"PLoS ONE"},{"key":"BFsrep17166_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/76095","volume":"25","author":"A Follenzi","year":"2000","unstructured":"Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M. & Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217\u2013222 (2000).","journal-title":"Nat. Genet."},{"key":"BFsrep17166_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/nar\/25.5.1078","volume":"25","author":"A Hoffmann","year":"1997","unstructured":"Hoffmann, A., Villalba, M., Journot, L. & Spengler, D. A novel tetracycline-dependent expression vector with low basal expression and potent regulatory properties in various mammalian cell lines. Nucleic Acids Res. 25, 1078\u20131079 (1997).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep17166_CR25","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1128\/AEM.02701-13","volume":"79","author":"AW Debowski","year":"2013","unstructured":"Debowski, A. W., Verbrugghe, P., Sehnal, M., Marshall, B. J. & Benghezal, M. Development of a tetracycline-inducible gene expression system for the study of helicobacter pylori pathogenesis. Appl. Environ. Microbiol. 79, 7351\u20137359 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFsrep17166_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/dvg.22414","volume":"51","author":"E Fiorini","year":"2013","unstructured":"Fiorini, E. et al. Inducible gene expression in fetal thymic epithelium: a new BAC transgenic model. Genesis 51, 717\u2013724 (2013).","journal-title":"Genesis"},{"key":"BFsrep17166_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","volume":"9","author":"L Sastry","year":"2002","unstructured":"Sastry, L., Johnson, T., Hobson, M., Smucker, B. & Cornetta, K. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9, 1155\u20131162 (2002).","journal-title":"Gene Ther."},{"key":"BFsrep17166_CR28","doi-asserted-by":"publisher","first-page":"12381","DOI":"10.1128\/JVI.76.23.12381-12387.2002","volume":"76","author":"JL Clever","year":"2002","unstructured":"Clever, J. L., Miranda, D. & Parslow, T. G. RNA structure and packaging signals in the 5\u2032 leader region of the human immunodeficiency virus type 1 genome. J. Virol. 76, 12381\u201312387 (2002).","journal-title":"J. Virol."},{"key":"BFsrep17166_CR29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/sj.gt.3301981","volume":"10","author":"A Dancer","year":"2003","unstructured":"Dancer, A. et al. Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice. Gene Ther. 10, 1170\u20131178 (2003).","journal-title":"Gene Ther."},{"key":"BFsrep17166_CR30","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1038\/sj.onc.1208483","volume":"24","author":"M-H Prandini","year":"2005","unstructured":"Prandini, M.-H. et al. The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene 24, 2992\u20133001 (2005).","journal-title":"Oncogene"},{"key":"BFsrep17166_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.abb.2008.11.016","volume":"482","author":"D Lopez","year":"2009","unstructured":"Lopez, D., Niu, G., Huber, P. & Carter, W. B. Tumor-induced upregulation of twist, snail and Slug represses the activity of the human VE-cadherin promoter. Arch. Biochem. Biophys. 482, 77\u201382 (2009).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFsrep17166_CR32","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1161\/01.CIR.0000096490.16596.A6","volume":"108","author":"DP Griese","year":"2003","unstructured":"Griese, D. P. et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108, 2710\u20132715 (2003).","journal-title":"Circulation"},{"key":"BFsrep17166_CR33","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1101\/gad.3.7.1019","volume":"3","author":"N Levitt","year":"1989","unstructured":"Levitt, N., Briggs, D., Gil, A. & Proudfoot, N. J. Definition of an efficient synthetic poly(A) site. Genes Dev. 3, 1019\u20131025 (1989).","journal-title":"Genes Dev."},{"key":"BFsrep17166_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2009.22","volume":"4","author":"RH Kutner","year":"2009","unstructured":"Kutner, R. H., Zhang, X.-Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protocols 4, 495\u2013505 (2009).","journal-title":"Nat. Protocols"},{"key":"BFsrep17166_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/104303403764539387","volume":"14","author":"G Liz\u00e9e","year":"2003","unstructured":"Liz\u00e9e, G. et al. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum. Gene Ther. 14, 497\u2013507 (2003).","journal-title":"Hum. Gene Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep17166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:57:19Z","timestamp":1672948639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep17166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep17166"],"URL":"https:\/\/doi.org\/10.1038\/srep17166","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,27]]},"assertion":[{"value":"15 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent has been filed based on the results presented in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17166"}}